Institutions / TIG Advisors, LLC

TIG Advisors, LLC

CIK 1358253 · Institution · as of Mar 31, 2026
Portfolio value
$2.09B
Positions
96
As of
Mar 31, 2026

Portfolio trend

Portfolio value

$2.09B+1.0%
$2.09B$2.08B$2.07BQ4 '25Q1 '26

Positions

96+52.4%
968063Q4 '25Q1 '26

Top holdings

Mar 31, 2026View all 96 →
CompanyClassValueShares% of portfolio
SPDR Series Trust$456.26M5,960,51421.8%
Clearwater Analytics Holdings, Inc.$118.66M5,017,1855.7%
Hologic Inc$100.92M1,335,1174.8%
Warner Bros. Discovery, Inc.$98.40M3,583,3694.7%
Janus Henderson Group PLC$97.92M1,906,1074.7%
Norfolk Southern Corp$96.49M336,1984.6%
Electronic Arts Inc.$83.16M407,9004.0%
Sealed Air Corp$68.66M1,632,8753.3%
Arcellx, Inc.$62.16M541,3783.0%
Amicus Therapeutics Inc$55.32M3,825,4452.6%
SunocoCorp LLCSUNCCommon Stock$51.63M837,3992.5%
Apellis Pharmaceuticals, Inc.$50.41M1,252,9862.4%
DigitalBridge Group, Inc.$46.22M2,997,6502.2%
Webster Financial Corp$42.69M614,9902.0%
Onestream, Inc.$41.72M1,738,2312.0%
State Str SPDR S&P 500 ETF T$37.31M57,3721.8%
Qorvo, Inc.$36.24M468,2251.7%
Chart Industries Inc$33.99M164,3841.6%
Kenvue Inc.$29.73M1,724,6281.4%
Silicon Laboratories Inc$29.69M142,6331.4%
Unifirst Corp$29.65M117,8521.4%
Sumisho Air Lease Corp$29.46M453,7241.4%
Terns Pharmaceuticals, Inc.$26.95M511,1911.3%
Centessa Pharmaceuticals PLC$25.75M648,3261.2%
Aes Corp$25.27M1,793,2441.2%

Activity

InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q1 2026
as of
ExitAvidity Biosciences, Inc.
Common stock
$-129.96M-1.8M
-100.00%
0
high
Q1 2026
as of
ExitM2682V108
Common stock
$-100.48M-225K
-100.00%
0
high
Q1 2026
as of
NewJanus Henderson Group PLC
Common stock
$97.92M+1.9M
1,906,107
4.67% of portfolio
high
Q1 2026
as of
Exit35909D109
Common stock
$-90.56M-2.4M
-100.00%
0
high
Q1 2026
as of
ExitExact Sciences Corp.
Common stock
$-89.76M-884K
-100.00%
0
high
Q1 2026
as of
ExitG29687103
Common stock
$-83.16M-3.9M
-100.00%
0
high
Q1 2026
as of
ExitDayforce, Inc.
Common stock
$-72.47M-1.0M
-100.00%
0
high
Q1 2026
as of
NewArcellx, Inc.
Common stock
$62.16M+541K
541,378
2.97% of portfolio
high
Q1 2026
as of
AddClearwater Analytics Holdings, Inc.
Common stock
$56.87M+2.4M
+92.05%
5,017,185
5.66% of portfolio
high
Q1 2026
as of
NewApellis Pharmaceuticals, Inc.
Common stock
$50.41M+1.3M
1,252,986
2.41% of portfolio
high